[DOI] [PMC free article] [PubMed] [Google Scholar] 146.Hutchison A.T., Piscitelli D., Horowitz M., Jones K.L., Clifton P.M., Standfield S., Hausken T., Feinle-Bisset C., Luscombe-Marsh N.D
Wegovy is the first oral semaglutide formulation specifically approved for weight loss
Available at: New Beauty
This simplified the trial design but raises legitimate questions about whether weight-based dosing might improve outcomes
Some people lose muscle during GLP-1 treatment because appetite drops, total food intake decreases, and protein intake may become too low
Did you know that new weight loss medications, such as GLP-1 and GLP-1 & GIP therapies, can make losing weight easier by reducing appetite, regulating blood sugar levels, and increasing your energy levels